Compare · COCH vs SNN
COCH vs SNN
Side-by-side comparison of Envoy Medical Inc. (COCH) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COCH and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $12.41B, about 215.3x COCH ($57.7M).
- Over the past year, COCH is down 36.4% and SNN is down 21.7% - SNN leads by 14.8 points.
- SNN has been more active in the news (14 items in the past 4 weeks vs 4 for COCH).
- SNN has more recent analyst coverage (25 ratings vs 2 for COCH).
- Company
- Envoy Medical Inc.
- Smith & Nephew SNATS Inc.
- Price
- $0.75+2.71%
- $29.21-1.43%
- Market cap
- $57.7M
- $12.41B
- 1M return
- +9.86%
- -6.18%
- 1Y return
- -36.44%
- -21.68%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 14
- Recent ratings
- 2
- 25
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest COCH
- SEC Form PRE 14A filed by Envoy Medical Inc.
- Envoy Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- SEC Form 10-Q filed by Envoy Medical Inc.
- Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
- Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
- Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
- Envoy Medical Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
- Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
- Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
- Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Analyst
- Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week